Novel B7H3 ADC Yields Responses in Cervical Cancer and Platinum-Resistant Ovarian Cancer
Treatment with DB-1311/BNT324, a novel B7H3 antibody-drug conjugate (ADC), resulted in antitumor activity among patients with previously treated cervical cancer or platinum-resistant ovarian cancer (PROC),...
